A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose Frequency Study of Intravenous Ketamine in Patients with Treatment-Resistant Depression

被引：0

作者：

Singh, Jaskaran ^{[1
]}

Fedgchin, Maggie ^{[1
]}

Daly, Ella ^{[1
]}

De Boer, Peter ^{[2
]}

Cooper, Kimberly ^{[3
]}

Lim, Pilar ^{[4
]}

Pinter, Christine ^{[5
]}

Murrough, James ^{[6
]}

Sanacora, Gerard ^{[7
]}

Shelton, Richard ^{[8
]}

Kurian, Benji ^{[9
]}

Winokur, Andrew ^{[10
,11
]}

Fava, Maurizio ^{[12
,13
]}

Manji, Husseini ^{[1
]}

Drevets, Wayne ^{[1
]}

Van Nueten, Luc ^{[2
]}

机构：

[1] Janssen Res & Dev LLC, Neurosci, Titusville, NJ USA

[2] Janssen Res & Dev LLC, Neurosci, Beerse, Belgium

[3] Janssen Res & Dev LLC, Clin Biostat, Spring House, PA USA

[4] Janssen Res & Dev LLC, Clin Biostat, Titusville, NJ USA

[5] Janssen Res & Dev LLC, GTM, Titusville, NJ USA

[6] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA

[7] Yale Univ, Sch Med, New Haven, CT USA

[8] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA

[9] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA

[10] Inst Living, Hartford, CT USA

[11] Univ Connecticut, Farmington, CT USA

[12] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA

[13] Harvard Univ, Sch Med, Boston, MA USA

来源：

BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期

关键词：

Ketamine; Treatment-Resistant Depression; Efficacy; Safety;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

144

引用

页码：44S / 44S

页数：1

共 50 条

[1] A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Singh, Jaskaran B.
Fedgchin, Maggie
Daly, Ella J.
De Boer, Peter
Cooper, Kimberly
Lim, Pilar
Pinter, Christine
Murrough, James W.
Sanacora, Gerard
Shelton, Richard C.
Kurian, Benji
Winokur, Andrew
Fava, Maurizio
Manji, Husseini
Drevets, Wayne C.
Van Nueten, Luc
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08): : 816 - 826
[2] Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study
Singh, J.
Fedgchin, M.
Daly, E.
De Boer, P.
Cooper, K.
Lim, P.
Pinter, C.
Murrough, J.
Sanacora, G.
Shelton, R.
Kurian, B.
Winokur, A.
Fava, M.
Manji, H.
Drevets, W.
Van Nueten, L.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S387 - S388
[3] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial
Ohtani, Yohei
Tani, Hideaki
Nomoto-Takahashi, Kie
Yatomi, Taisuke
Yonezawa, Kengo
Tomiyama, Sota
Nagai, Nobuhiro
Kusudo, Keisuke
Honda, Shiori
Moriyama, Sotaro
Nakajima, Shinichiro
Yamada, Takashige
Morisaki, Hiroshi
Iwabuchi, Yu
Jinzaki, Masahiro
Yoshimura, Kimio
Eiro, Tsuyoshi
Tsugawa, Sakiko
Ichijo, Sadamitsu
Fujimoto, Yu
Miyazaki, Tomoyuki
Takahashi, Takuya
Uchida, Hiroyuki
[J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024,
[4] Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Yonezawa, Kengo
Uchida, Hiroyuki
Yatomi, Taisuke
Ohtani, Yohei
Nomoto-Takahashi, Kie
Nakajima, Shinichiro
Mimura, Masaru
Tani, Hideaki
[J]. PHARMACOPSYCHIATRY, 2024, 57 (01) : 35 - 40
[5] Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Fava, Maurizio
Freeman, Marlene P.
Flynn, Martina
Judge, Heidi
Hoeppner, Bettina B.
Cusin, Cristina
Ionescu, Dawn F.
Mathew, Sanjay J.
Chang, Lee C.
Iosifescu, Dan V.
Murrough, James
Debattista, Charles
Schatzberg, Alan F.
Trivedi, Madhukar H.
Jha, Manish K.
Sanacora, Gerard
Wilkinson, Samuel T.
Papakostas, George I.
[J]. MOLECULAR PSYCHIATRY, 2020, 25 (07) : 1592 - 1603
[6] Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava
Marlene P. Freeman
Martina Flynn
Heidi Judge
Bettina B. Hoeppner
Cristina Cusin
Dawn F. Ionescu
Sanjay J. Mathew
Lee C. Chang
Dan V. Iosifescu
James Murrough
Charles Debattista
Alan F. Schatzberg
Madhukar H. Trivedi
Manish K. Jha
Gerard Sanacora
Samuel T. Wilkinson
George I. Papakostas
[J]. Molecular Psychiatry, 2020, 25 : 1604 - 1604
[7] Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Singh, Jaskaran B.
Fedgchin, Maggie
Daly, Ella
Xi, Liwen
Melman, Caroline
De Bruecker, Geert
Tadic, Andre
Sienaert, Pascal
Wiegand, Frank
Manji, Husseini
Drevets, Wayne C.
Van Nueten, Luc
[J]. BIOLOGICAL PSYCHIATRY, 2016, 80 (06) : 424 - 431
[8] A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Paulo R. Shiroma
Paul Thuras
Joseph Wels
C. Sophia Albott
Christopher Erbes
Susannah Tye
Kelvin O. Lim
[J]. Translational Psychiatry, 10
[9] A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Shiroma, Paulo R.
Thuras, Paul
Wels, Joseph
Albott, C. Sophia
Erbes, Christopher
Tye, Susannah
Lim, Kelvin O.
[J]. TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)
[10] Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study
Aftanas, L. I.
Markov, A. A.
Rikita, M. V.
Danilenko, K. V.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S189 - S189

← 1 2 3 4 5 →